Filter
577
Text search:
injectable
medicines
Featured
Recommendations
105
New Publications
180
Language
Document type
No document type
313
Guidelines
118
Studies & Reports
63
Manuals
38
Fact sheets
14
Strategic & Response Plan
13
Training Material
12
Situation Updates
4
Resource Platforms
1
Infographics
1
Countries / Regions
Kenya
23
Global
22
Western and Central Europe
20
India
18
Nepal
17
Malawi
16
South Africa
15
Ethiopia
13
Zambia
12
Namibia
12
Eastern Europe
12
Nigeria
11
Uganda
11
Tanzania
11
Bangladesh
11
Rwanda
9
Myanmar / Burma
9
Africa
9
Liberia
8
Senegal
8
Sierra Leone
6
Ghana
6
Latin America and the Carribbean
6
Haiti
5
Congo, Democratic Republic of
4
Zimbabwe
4
Middle East and North Africa
4
Guinea
3
Burkina Faso
3
Syria
3
Benin
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Tajikistan
3
Russia
3
Georgia
3
Mali
2
Cameroon
2
Philippines
2
Lebanon
2
Mozambique
2
Lesotho
2
East and Southern Africa
2
West and Central Africa
2
Asia
2
Timor Leste/ East Timor
2
Iran
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Somalia
1
Pakistan
1
South Sudan
1
Iraq
1
Jordan
1
Turkey
1
Cambodia
1
Gambia
1
Sudan
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Ukraine
1
Botswana
1
Greece
1
Libya
1
Albania
1
Armenia
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
228
Clinical Guidelines
95
Women & Child Health
51
Public Health
32
Key Resources
19
Pharmacy & Technologies
10
Capacity Building
6
Toolboxes
TB
85
HIV
58
Pharmacy
40
Malaria
21
Caregiver
19
COVID-19
17
Mental Health
15
AMR
12
NCDs
11
NTDs
9
Ebola & Marburg
8
Conflict
5
Rapid Response
4
Refugee
4
Health Financing Toolbox
4
Natural Hazards
2
Polio
1
Social Ethics
1
Planetary Health
1
In recent decades, India has witnessed a rapidly exploding epidemic of diabetes.
Indeed, India today has the second largest number of people with diabetes in the
world. The International Diabetes Federation (IDF) estimates that there are 72.9 million people with diabetes in India in 2017, which is
...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of
...
The Abuja declaration identifies that the prevention and control of HIV/AIDS, tuberculosis and related infectious diseases must come with additional financial resources. Therefore, African governments agreed on setting the target of allocating at least 15 per cent of each country’s annual budget
...
HIV & AIDS Treatment in Practice No.202
This executive summary contains all the new recommendations that will be incorporated into the fifth edition of the Medical eligibility criteria (MEC) for contraceptive use. In addition to the recommendations themselves, the summary provides an introduction to the guideline, a description of the met
...
As a lower-middle-income country (LMIC), South Africa (SA) bears
the burden of maternal and neonatal mortality similar to other sub-
Saharan African countries. According to the Saving Mothers Report
2017/19, there has been a progressive and sustained reduction
in institutional maternal mortality
...
The WHO Trauma Bag 2021 is intended to provide the resources needed to care for care of acutely ill and injured patients in hospital emergency units, field hospitals or clinics providing acute care. The Trauma Bag may also be applicable in prehospital settings if care is provided by advanced practi
...
A nationwide survey of a representative sample of health facilities across public health services in all states and regions of Myanmar has been undertaken since 2014 to track Reproductive Health Commodity Security (RHCS) indicators, such as the availability of reproductive health (RH) commodities; t
...
A consolidated set of reproductive health kits for use by humanitarian agencies. These kits are intended to speed up the provision of appropriate reproductive health services in emergency and refugee situations.
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
